If you cannot find an answer to your question on this page please contact our medical director Dr Jo Scott-Jones on
027 475 0488.
On this page
Please notify your providers of this change to ordering processes. There will be notification on the ProPharma website from Monday. We would appreciate if you could remind providers that the national priority groups for MMR vaccination remain unchanged:
Distribution levels of MMR will continue to be monitored daily. The Ministry of Health has worked with DHBs to gather a good understanding of expected usage until the end of 2019. Any significant increase in usage above expected levels will be investigated to ensure that all regions and priority groups continue to receive appropriate levels of vaccine.
Ordering the MMR vaccine through regional distribution centres outside of Auckland will begin on 9 December 2019.
Pharmacies in the Auckland region that have a contract with their DHB to deliver MMR vaccines should continue to use the Auckland region process to order. Delivery to pharmacies has now been enabled and will commence on 9 December 2019.
Pharmacies outside of the Auckland region, that have a contract with their DHB to deliver MMR vaccines, will need to send their business name and address and any existing ProPharma account number or SAP code to yourselves and/or the Pharmacy Portfolio manager for your DHB, so that you are aware of which pharmacy are accessing MMR vaccines. Please then provide a list of pharmacies to firstname.lastname@example.org so that PHARMAC are able to work with the regional distribution centres to enable delivery of MMR vaccine.
The question about eligibility for vaccination was
raised and confirmed that:
Eligibility criteria and claiming
The eligibility criteria for publicly funded vaccinations states:
Regardless of their citizenship or immigration status, children are eligible for publicly funded vaccinations on the Immunisation Schedule, and WellChild/Tamariki Ora services.
You can also find this information on the Ministry
of Health website- vaccine
Claiming for vaccinating children who are not New Zealand citizens follows the same process as claiming for those who are citizens. This includes claiming for the vaccine and administration. Information is available in the Immunisation Handbook page 12.
Those over the age of 18 and who are not residents or citizens are ineligible - eligibility criteria can be found here eligibility criteria.
Some districts have patient specific resources on their websites. For those without we have attached to the bottom of this page a series of resources developed from the Auckland Regional Public Health information (thank you Dave Maplesden).
Consider referring to NIR for outreach immunisation referrals for your 15 month and 4 year olds - this increases the options for your patients getting access to vaccination, it doesn't mean you can't do these immunisations yourselves if you can, it's just another option for access.
Please be mindful when speaking to concerned members of the public that if you are out of stock the message is clear they are eligible to be vaccinated - confusion is evident on Facebook where patients have been turned away due to stock issues.
Waikato - 2pm, 23 September
We will collect "stock on hand" data using this form on Monday and Thursday each week.
On Thursday 26 September (this week) we will also ask practices to tell us how many CHILDREN you are going to recall for MMR vaccination in the next two weeks.
This data will be sent to the Ministry of Health and used to:
Supplies are at such a low level (240 doses every 2 weeks for 92 practices across the district) that practices may well be sent just enough vaccines to cover the number of children they have booked in.
The DHB will be using NIR data to check the doses required and doses actually given at a practice level.
The DHB is getting reports of practice still giving vaccine to people for occupational purposes (including adult DHB employees). Practices are reminded that ONLY children who are not fully immunised should be getting MMR vaccines, and we are encouraged to actively recall all children up to the age of 5 years.
Unimmunised contacts of proven measles cases may be advised to have an MMR vaccine, but they will have been asked to do so by public health, and children travelling to measles prone areas may be vaccinated out of scheduled times.
The key contact for vaccine distribution concerns in the Waikato is David Wilson.
This is being coordinated by Helen Thomas.
This is being coordinated by Matt Tong.
If you have patients with concerns who require general information you may wish to point them towards the HealthNavigator information on measles. This is prepared with the general public in mind.
There have recently been new cases in Waikato with multiple contacts - we have attached information sheets for patients (and practices) that can be used to address enquiries.
The Immunisation Advisory Centre (IMAC) web page "Measles overseas and in New Zealand" is an excellent source of up to date information. It contains:
Also see the Ministry of Health information for health professionals web page for a range of downloadable/printable resources and advice.
Measles is one of the most contagious of all infectious diseases - up to 9 out of 10 susceptible persons with close contact to a measles patient will develop measles. The virus is transmitted by direct contact with infectious droplets or by airborne spread when an infected person breathes, coughs, or sneezes. It survives in the air for up to two hours after the person has left the room. There is a risk of contracting measles after only 15 minutes in a room with a contagious patient.
After the triage and isolation area has been vacated surfaces should be washed down with a disinfectant following the instructions on the product. The New Zealand Ministry of Health recommend that a when a person with a high suspicion of measles has been in a room it is left vacant for ONE hour after their departure. Staff dealing with patients in the triage and isolation areas should wash their hands before and after contact with the patient.
It's complicated. There is a comprehensive re-vaccination schedule that details the vaccinations that could be needed depending on the particular case.
The inclusion of funded vaccines for "revaccination post-chemotherapy" on the Pharmaceutical Schedule provides an indication of what can be given when required rather than an instruction of what must be given regardless of the individual's age and documented vaccination records. As per the Handbook, "Oncology patients - this section provides general guidelines for vaccination after cancer treatment. Specific vaccination questions should be discussed with an expert paediatrician, infectious diseases physician or oncologist." Use of the word "revaccination" may be causing some confusion. Best practice is that individuals who have a complete documented primary course of vaccines prior to chemotherapy do not need to repeat a primary course of the vaccines post-chemotherapy. Starship guidelines do not to follow this evidence but the advice for those aged 18 years or older does.
In the case of MMR vaccination for adults post-chemotherapy, the first criteria is that the adult is non-immune to measles, mumps and rubella. If they were considered immune before chemotherapy, they are still considered immune to measles, mumps and rubella after.
Adults born prior to 1969 are considered immune to measles therefore vaccinating these adults post-chemotherapy is not indicated.
Adults born 1969 or later
If a patient has had one vaccine as a child, and is now 49 years of age, should they have another vaccine?
Yes, but there is no urgency about this - a single vaccine will provide cover for 95 per cent of the population, the second vaccine "booster" can pick up another 3 per cent or so.
Helen Ride, Pinnacle Midlands Health Network
Phone 021 683 977 or email email@example.com
Mel Hurliman, Taranaki DHB
Phone (06) 753 7702 extn 8680 / 027 211 6357 or email firstname.lastname@example.org
Kim Winckel, Lakes DHB - available Thursday, Friday and alternate Wednesdays, 8am-4.30pm
Phone (07) 343 7759 / 027 513 0931 or email email@example.com
Janine Brown, Hauora Tairawhiti
Phone (06) 869 2092 extn 8765 or email firstname.lastname@example.org